Professor of Medicine, Saint Louis University
Infectious Disease
Dr. Sharon E. Frey, MD
|
|
Give Review
Sharon Frey works in the field of Infectious Disease. She graduated from St Louis University School of Medicine. She received awards:"Whos Who in Medicine and Healthcare". Sharon E. Frey, MD has written publications. She has 82 publications published with PubMed. The lastest publication is: 'A dose response study of hepatitis A vaccine in healthy adults who are > or = 30 years old and weigh > or = 77 kg.'
Publications
- Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1)...
- Robust mucosal-homing antibody-secreting B cell responses induced by intramuscular administration of adjuvanted bivalent human norovirus-like particle vaccine.
- Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial.
- Assessment of congenital anomalies in infants born to pregnant women enrolled in clinical trials.
- Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial.
- Phase I/II Randomized Trial of Safety and Immunogenicity of LIPO-5 Alone, ALVAC-HIV (vCP1452) Alone, and ALVAC-HIV (vCP1452) Prime/LIPO-5 Boost in Healthy, HIV-1 Uninf...
- A Novel Intramuscular Bivalent Norovirus VLP Vaccine Candidate - Reactogenicity, Safety and Immunogenicity in a phase I trial in healthy adults.
- Genetic and antigenic typing of seasonal influenza breakthrough cases from a 2008-2009 vaccine efficacy trial.
- A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen ...
- Rapid, Sensitive Recovery of Recombinant Attenuated Salmonella enterica serovar Typhi Vaccine Strains from Human Blood.
- CD4+ T Cells Provide Intermolecular Help To Generate Robust Antibody Responses in Vaccinia Virus-Vaccinated Humans.
- Safety and immunogenicity of IMVAMUNE(®) smallpox vaccine using different strategies for a post event scenario.
- Prospective surveillance for cardiac adverse events in healthy adults receiving modified vaccinia ankara vaccines: a systematic review.
- Safety and Immune Responses in Children After Concurrent or Sequential 2009 H1N1 and 2009-2010 Seasonal Trivalent Influenza Vaccinations.
- Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults.
- Immunogenicity of an Inactivated Monovalent 2009 H1N1 Influenza Vaccine in Pregnant Women.
- A weak neutralizing antibody response to hepatitis C virus envelope glycoprotein enhances virus infection.
- Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymp...
- Characterization of antibodies induced by vaccination with hepatitis C virus envelope glycoproteins.
- Electrocardiography screening for cardiotoxicity after modified Vaccinia Ankara vaccination.
- Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax.
- The immunogenetics of smallpox vaccination.
- Antibody responses to vaccinia membrane proteins after smallpox vaccination.
- Lack of transmission of vaccinia virus.
- Flow-cytometric detection of vaccinia-induced memory effector CD4(+), CD8(+), and gamma delta TCR(+) T cells capable of antigen-specific expansion and effector functions.
- Immune status in a primary smallpox vaccinee who failed to develop an immunization site reaction.
- Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination.
- Dose-dependent neutralizing-antibody responses to vaccinia.
- Poxvirus zoonoses--putting pocks into context.
- Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine.
- Response to smallpox vaccine in persons immunized in the distant past.
- Stability of undiluted and diluted vaccinia-virus vaccine, Dryvax.
- Unique risks to volunteers in HIV vaccine trials.
- Dose-related effects of smallpox vaccine.
- Evidence for probable sexual transmission of the hepatitis g virus.
- Interlaboratory trial on the analysis of alkylphenols, alkylphenol ethoxylates, and bisphenol A in water samples according to ISO/CD 18857-2.
- Chemosensory event-related potentials in relation to side of stimulation, age, sex, and stimulus concentration.
- The presence or absence of gp120/gp160 bands on indeterminate western blots: predictive value for HIV seroconversion.
- Treatment of methicillin-resistant Staphylococcus aureus infection with quinupristin/dalfopristin.
- Measuring injection-site pain associated with vaccine administration in adults: a randomised, double-blind, placebo-controlled clinical trial.
- A rod in the spine.
- Bacteremia associated with live attenuated chi8110 Salmonella enterica serovar Typhi ISP1820 in healthy adult volunteers.
- HIV vaccines.
- Temperature dependence of cell-cell fusion induced by the envelope glycoprotein of human immunodeficiency virus type 1.
- A dose response study of hepatitis A vaccine in healthy adults who are > or = 30 years old and weigh > or = 77 kg.
- Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers.
- Safety, tolerability and immunogenicity of low dose Haemophilus influenzae type b conjugated to the outer membrane protein complex of Neisseria meningitidis group B.
- Effects of antigen dose and immunization regimens on antibody responses to a cytomegalovirus glycoprotein B subunit vaccine.
- Clinical efficacy of cell culture–derived and eggâ€Âderived inactivated subunit influenza vaccines in healthy adults.
- HIV-1 recombinant gp160 vaccine given in accelerated dose schedules. NIAID AIDS Vaccine Clinical Trials Network.
- Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers.
- High-dose recombinant Canarypox vaccine expressing HIV-1 protein, in seronegative human subjects.
- Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine.
- Lymphocyte proliferative responses following immunization with human immunodeficiency virus recombinant GP160. The NIAID AIDS Vaccine Clinical Trials Network.
- In silico-accelerated identification of conserved and immunogenic variola/vaccinia T-cell epitopes.
- Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration. National Institute of Allergy and Infectious Diseases ...
- A dose-ranging study of a prototype synthetic HIV-1MN V3 branched peptide vaccine. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Gr...
- Vaccine-induced antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins. NIAID AIDS Vaccine Clinical Trials Network.
- HIV-1 recombinant gp160 vaccine induced antibodies in serum and saliva. The NIAID AIDS Vaccine Clinical Trials Network.
- Detection of binding antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins following recombinant gp160 immunization measured ...
- Long-term memory B-cell responses in recipients of candidate human immunodeficiency virus type 1 vaccines.
- Comparison of the safety, tolerability, and immunogenicity of a MF59-adjuvanted influenza vaccine and a non-adjuvanted influenza vaccine in non-elderly adults.
- Long-term safety analysis of preventive HIV-1 vaccines evaluated in AIDS vaccine evaluation group NIAID-sponsored Phase I and II clinical trials.
- Clinical responses to undiluted and diluted smallpox vaccine.
- Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Gr...
- Safety profile of recombinant canarypox HIV vaccines.
- Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial.
- Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults.
- Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adults.
- Possible autoimmune reactions following smallpox vaccination: the biologic false positive test for syphilis.
- Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial.
- Clinical and immunologic responses to multiple doses of IMVAMUNE (Modified Vaccinia Ankara) followed by Dryvax challenge.
- The new ACAM2000 vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks.
- Evaluation of smallpox vaccines using variola neutralization.
- Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus.
- Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults.
- A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers.
- Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant.
- Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles.
- A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects.
- VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone.
Schools
Marshall University
SUNY Hsc
St Louis University Hospital
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Awards
- Whos Who in Medicine and Healthcare
Education
-
St Louis University School of Medicine -
SUNY Upstate Medical University -
Marshall University Joan C. Edwards School of Medicine
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1356359228 |
| Last Name Of The Provider | FREY |
| First Name Of The Provider | SHARON |
| View All |
Similar Doctors
|
|
Dr. Omer M. Badahman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Janelle A. Moore, PT |
|
|
Dr. Francisco M. Pherez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Morey Gardner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erik C. Stabell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip J. Budge, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frederick M. Kuhlmann, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah L. George, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen Y. Liang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melissa Viray, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Keith F. Woeltje, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rajashree Gottimukkula, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nur F. Onen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maria A. Reyes, MD |
|
|
Dr. William G. Powderly, MD
This Doctor is OpenDoctor Recommended.
|